“…Against bacterial strains, such as E. coli, B. subtilis, and S. aureus, MICs were significantly low ranging from 0.0625-1.000 and 0.5-19 µg/mL. In 2015, P. Arthi and coworkers reported a series of pendant-armed Schiff base hexaaza macrocycles manganese(II) complexes by the condensation of equimolar amounts of terephthalaldehyde and N,N-bis(2-aminoethyl)benzamide derivatives in the presence of Mn(ClO 4 ) 2 •6H 2 O as a templating agent (15, Figure 3) [55]. In comparison to the standard drug, ciprofloxacin, the complexes showed good activities against both Gram-negative (K. pneumoniae, P. aeruginosa, V. alginolyticus, V. cholerae and V. harveyi) and Gram-positive (S. aureus and S. mutans) bacterial strains.…”